Tolerance and clinical response to SGL2 inhibitors in Fabry disease

被引：0
|
作者：
Mattig, I. [1 ]
Bonnekoh, C. [2 ]
Zirkelbach, B. [1 ]
Stangl, K. [1 ]
Hindricks, G. [1 ]
Knebel, F. [3 ]
Canaan-Kuehl, S. [2 ]
Spethmann, S. [1 ]
机构：
[1] Charite, Deutsch Herzzentrum Charite, Berlin, Germany
[2] Charite, Berlin, Germany
[3] Sana Klinikum Berlin Lichtenberg, Cardiol, Berlin, Germany
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：236 / 236
页数：1
相关论文
共 50 条
  • [1] SAN GIOVANNI IN LATERANO 2 PROJECT (SGL2)
    Ravasi, Thea
    Liverani, Paolo
    Haynes, Ian
    Kay, Stephen
    PAPERS OF THE BRITISH SCHOOL AT ROME, 2020, 88 : 350 - 354
  • [2] y Inhibition of SGL2 Prevents Albumin Induced Proximal Tubule Inflammation
    Almutlaq, Rawan
    Veiga, Amanda
    Dayton, Alex
    Guntipally, Sridhatri
    PHYSIOLOGY, 2024, 39
  • [3] Novel Insights about Synergistic Effect of Zamzam Water with SGL2 Inhibitors on Wound Healing in STZ-Induced Diabetic Rats: The Role of anti-Inflammatory and Proangiogenic Effects
    Taha, Medhat
    Elazab, Sara T.
    Qutub, Ammar
    Abdelbagi, Omer
    Baokbah, Tourki A. S.
    Ahmed, Gomaa S.
    Zaghloul, Randa A.
    Albarakati, Alaa Jameel A.
    Qusty, Naeem F.
    Babateen, Omar
    Al-Kushi, Abdullah G.
    JOURNAL OF INVESTIGATIVE SURGERY, 2023, 36 (01)
  • [4] Pulmonary disease and exercise tolerance in boys with Fabry disease
    Wilcox, William
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S39 - S39
  • [5] Pulmonary disease and exercise tolerance in boys with fabry disease
    Wilcox, William
    MOLECULAR GENETICS AND METABOLISM, 2009, 96 (02) : S46 - S46
  • [6] Synthesis of c-arylglucosides as SGL T2 inhibitors
    Murakata M.
    Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry, 2021, 79 (06): : 532 - 546
  • [7] Gastrointestinal manifestations of Fabry disease: Clinical response to enzyme replacement therapy
    Banikazemi, M
    Ullman, T
    Desnick, RJ
    MOLECULAR GENETICS AND METABOLISM, 2005, 85 (04) : 255 - 259
  • [8] Fabry disease: clinical outcomes of agalsidase enzyme replacement therapies - Response
    Lidove, Olivier
    Joly, Dominique
    Papo, Thomas
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (07) : 1235 - 1235
  • [9] Synthesis of C-Arylglucosides as SGL T2 Inhibitors
    Murakata, Masatoshi
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2021, 79 (06) : 532 - 546
  • [10] Immune response to enzyme replacement therapy in Fabry disease: Impact on clinical outcome?
    Hollak, C. E. M.
    Linthorst, G. E.
    MOLECULAR GENETICS AND METABOLISM, 2009, 96 (01) : 1 - 3
12345